more

HeartBeam (BEAT)

(Delayed Data from NSDQ)

$2.21 USD

+0.01 (0.45%)

Updated May 3, 2024 04:00 PM ET

After-Market: $2.23 +0.02 (0.90%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

Top 40% (100 out of 252)

Industry: Medical Info Systems

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Has BioTelemetry (BEAT) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research Published on November 15,2018

Is (BEAT) Outperforming Other Medical Stocks This Year?

BEATPositive Net Change

Zacks.com highlights: BioTelemetry, Ericsson, Intel, United States Cellular and Cigna

by Zacks Equity Research Published on November 07,2018

Zacks.com highlights: BioTelemetry, Ericsson, Intel, United States Cellular and Cigna

The Zacks Analyst Blog Highlights: NetApp, Atkore International Group, Bio Telemetry, and Chefs' Warehouse

by Zacks Equity Research Published on November 07,2018

The Zacks Analyst Blog Highlights: NetApp, Atkore International Group, Bio Telemetry, and Chefs' Warehouse

Mid-term Election to Propel Stocks Higher: 4 Picks

by Zacks Equity Research Published on November 06,2018

Strong U.S. economy and other fundamentals could help stocks soar following the mid-term elections, making some stocks apt for investment.

5 Relative Price Strength Stocks to Maximize Your Returns

by Nilanjan Choudhury Published on November 06,2018

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research Published on November 05,2018

BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Earnings Estimates Rising for BioTelemetry (BEAT): Will It Gain?

by Zacks Equity Research Published on November 02,2018

BioTelemetry (BEAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BEATPositive Net Change

Near-Term Outlook for Medical Services Industry Looks Bright

by Urmimala Biswas Published on October 30,2018

Growing importance of efficient healthcare management is positioning the providers of medical services well to benefit.

medical

Is BioTelemetry (BEAT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research Published on October 29,2018

Is (BEAT) Outperforming Other Medical Stocks This Year?

BEATPositive Net Change

BioTelemetry (BEAT) Q3 Earnings Preview: What to Look Out For

by Zacks Equity Research Published on October 23,2018

BioTelemetry (BEAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BEATPositive Net Change

Will Healthcare Arm Drive BioTelemetry's (BEAT) Q3 Earnings?

by Zacks Equity Research Published on October 23,2018

Product launches, synergies from LifeWatch acquisition and favorable payor mix are expected to have worked in favor of BioTelemetry's (BEAT) Healthcare arm in Q3.